Last reviewed · How we verify

[18F]Florbetaben

Ulsan University Hospital · Phase 3 active Small molecule

[18F]Florbetaben is a Small molecule drug developed by Ulsan University Hospital. It is currently in Phase 3 development for Imaging of amyloid plaques in the brain for the diagnosis and monitoring of Alzheimer's disease. Also known as: neuraceq, Neuraceq.

A radioligand used for the imaging of amyloid plaques in the brain.

A radioligand used for the imaging of amyloid plaques in the brain. Used for Imaging of amyloid plaques in the brain for the diagnosis and monitoring of Alzheimer's disease.

At a glance

Generic name[18F]Florbetaben
Also known asneuraceq, Neuraceq
SponsorUlsan University Hospital
TargetAmyloid beta
ModalitySmall molecule
Therapeutic areaNeurology
PhasePhase 3

Mechanism of action

It binds to amyloid beta plaques in the brain, allowing for the visualization of amyloid burden in individuals with Alzheimer's disease. This can aid in the diagnosis and monitoring of the disease.

Approved indications

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about [18F]Florbetaben

What is [18F]Florbetaben?

[18F]Florbetaben is a Small molecule drug developed by Ulsan University Hospital, indicated for Imaging of amyloid plaques in the brain for the diagnosis and monitoring of Alzheimer's disease.

How does [18F]Florbetaben work?

A radioligand used for the imaging of amyloid plaques in the brain.

What is [18F]Florbetaben used for?

[18F]Florbetaben is indicated for Imaging of amyloid plaques in the brain for the diagnosis and monitoring of Alzheimer's disease.

Who makes [18F]Florbetaben?

[18F]Florbetaben is developed by Ulsan University Hospital (see full Ulsan University Hospital pipeline at /company/ulsan-university-hospital).

Is [18F]Florbetaben also known as anything else?

[18F]Florbetaben is also known as neuraceq, Neuraceq.

What development phase is [18F]Florbetaben in?

[18F]Florbetaben is in Phase 3.

What does [18F]Florbetaben target?

[18F]Florbetaben targets Amyloid beta.

Related